Developing New Medicines for Serious Illnesses
Synthesis and Study of Medicinally Important Molecules
This research aims to create new chemical compounds that could become future treatments for conditions like cancer, neurological problems, and infections that are hard to treat.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11176099 on NIH RePORTER |
What this research studies
Our program focuses on making new natural and man-made molecules with the potential to treat cancer, neurological disorders, and drug-resistant infections. We want to understand exactly how these molecules work in the body and then improve them to become effective new medicines. By creating these complex molecules, we hope to overcome current challenges in drug discovery and bring new therapies closer to patients. This foundational work is a crucial first step in the long process of developing new drugs.
Who could benefit from this research
Good fit: This foundational work does not directly involve patients but aims to develop future treatments for individuals with cancer, neurological disorders, or drug-resistant infections.
Not a fit: Patients not affected by cancer, neurological disorders, or drug-resistant infections would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new and more effective medications for challenging diseases like cancer, neurological disorders, and drug-resistant infections.
How similar studies have performed: This program focuses on innovative chemical synthesis strategies to develop novel molecules, building upon existing knowledge in organic chemistry and drug discovery.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Dai, Mingji — Emory University
- Study coordinator: Dai, Mingji
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.